Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)

Clinical trial NCT05089656 · COMPLETED

Trial details

NCT number: NCT05089656
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Spinal Muscular Atrophy

Start date: 2022-02-01
Primary completion: 2024-11-12
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.